Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1PCAS Finland Oy
02 1Professional Compounding Centers of America dba PCCA
03 1Societa Italiana Medicinali Scandicci S.I.M.S., SrL
04 1W. R. GRACE & CO.-CONN.
01 1TETRAHYDROZOLINE HYDROCHLORIDE
02 1Tetrahydrozoline HCI
03 2Tetrahydrozoline Hydrochloride
01 1France
02 1Italy
03 1U.S.A
04 1United Kingdom
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
TETRAHYDROZOLINE HYDROCHLORIDE
NDC Package Code : 51014-7162
Start Marketing Date : 2017-09-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TETRAHYDROZOLINE HYDROCHLORIDE
NDC Package Code : 22568-1132
Start Marketing Date : 2021-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TETRAHYDROZOLINE HYDROCHLORIDE
NDC Package Code : 51927-1796
Start Marketing Date : 2013-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
TETRAHYDROZOLINE HYDROCHLORIDE
NDC Package Code : 12660-0048
Start Marketing Date : 1979-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
99
PharmaCompass offers a list of Tetrahydrozoline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tetrahydrozoline manufacturer or Tetrahydrozoline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tetrahydrozoline manufacturer or Tetrahydrozoline supplier.
PharmaCompass also assists you with knowing the Tetrahydrozoline API Price utilized in the formulation of products. Tetrahydrozoline API Price is not always fixed or binding as the Tetrahydrozoline Price is obtained through a variety of data sources. The Tetrahydrozoline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tetrahydrozoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetrahydrozoline, including repackagers and relabelers. The FDA regulates Tetrahydrozoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetrahydrozoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tetrahydrozoline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tetrahydrozoline supplier is an individual or a company that provides Tetrahydrozoline active pharmaceutical ingredient (API) or Tetrahydrozoline finished formulations upon request. The Tetrahydrozoline suppliers may include Tetrahydrozoline API manufacturers, exporters, distributors and traders.
click here to find a list of Tetrahydrozoline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tetrahydrozoline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tetrahydrozoline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tetrahydrozoline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tetrahydrozoline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tetrahydrozoline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tetrahydrozoline suppliers with NDC on PharmaCompass.
